Tacrolimus Pharmacokinetics in Lung Transplantation: New Strategies for Monitoring
- 30 September 2005
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (9) , 1315-1319
- https://doi.org/10.1016/j.healun.2004.09.001
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cyclosporin A Absorption Profiles in Pediatric Renal Transplant Recipients Predict the Risk of Acute RejectionTherapeutic Drug Monitoring, 2004
- International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejectionThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Achieving adequate cyclosporine exposure in liver transplant recipients: A novel strategy for monitoring and dosing using intravenous therapyLiver Transplantation, 2004
- Long-Term predictive value of cyclosporine microemulsion C2 level for chronic renal allograft dysfunctionTransplantation Proceedings, 2003
- Tacrolimus monitoring by simplified sparse sampling under the concentration time curveTransplantation Proceedings, 2003
- Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoringTransplantation Proceedings, 2003
- Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndromeThe Journal of Heart and Lung Transplantation, 2003
- INTRA‐ AND INTERINDIVIDUAL VARIATION IN THE PHARMACOKINETICS OF TACROLIMUS (FK506) IN KIDNEY TRANSPLANT RECIPIENTS—IMPORTANCE OF TROUGH LEVEL AS A PRACTICAL INDICATORInternational Journal of Urology, 1995
- Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.‐MS and microparticle enzyme immunoassay (MEIA).British Journal of Clinical Pharmacology, 1994
- Some suggestions for measuring predictive performanceJournal of Pharmacokinetics and Biopharmaceutics, 1981